ResearchANIK
ANIK: FY25 Deep Dive
Published 1 min read
Anika Therapeutics FY25 at $113M. NI $-11M; EPS $-0.76.
ANIK: FY25 Deep Dive
FY25 revenue $113M; OI $-11M; NI $-11M; EPS $-0.76.
Anika Therapeutics FY25 (Dec 31, 2025) at $113M revenue. OpInc $-11M; NI $-11M; EPS $-0.76. Medical Devices.
